Company research
Achilles Therapeutics plc
CIK 1830749Updated Nov 16, 2026
Securities
Historical securities (1)
ACHL · NASDAQ · adr · closed Mar 20, 2025Name history
Achilles Therapeutics Ltd · through Feb 3, 2021
ACHL price & chart
Historical security
This listing closed Mar 20, 2025. Live provider charts are shown only for current listings.
In the news
No coverage from other publishers is available.
Recent filings
No filing activity has been returned.
Financials
FY 2023 · USDSource
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 161,456,000Source | 220,358,000Source | 317,106,000Source | 218,918,000Source |
| Property, Plant and Equipment, NetUSD | 9,171,000Source | 12,399,000Source | 17,743,000Source | 13,369,000Source |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 131,539,000Source | 173,338,000Source | 266,319,000Source | 177,849,000Source |
| Assets, CurrentUSD | 145,633,000Source | 196,580,000Source | 284,749,000Source | 187,797,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 14,094,000Source | 23,242,000Source | 18,430,000Source | 9,948,000Source |
| Operating Lease, Right-of-Use AssetUSD | 4,372,000Source | 8,081,000Source | 11,048,000Source | 14,740,000Source |
| Other Assets, NoncurrentUSD | 2,206,000Source | 3,014,000Source | 3,507,000Source | 3,008,000Source |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 19,087,000Source | 23,314,000Source | 27,578,000Source | 29,546,000Source |
| Stockholders’ equity: | ||||
| Common Stock, Value, IssuedUSD | 54,000Source | 54,000Source | 54,000Source | 6,000Source |
| Additional Paid in CapitalUSD | 415,210,000Source | 408,844,000Source | 401,821,000Source | 234,922,000Source |
| Retained Earnings (Accumulated Deficit)USD | -259,952,000Source | -190,287,000Source | -119,111,000Source | -58,012,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | -13,071,000Source | -21,695,000Source | 6,636,000Source | 12,322,000Source |
| Stockholders' Equity Attributable to ParentUSD | 142,369,000Source | 197,044,000Source | 289,528,000Source | 189,372,000Source |
| Liabilities and EquityUSD | 161,456,000Source | 220,358,000Source | 317,106,000Source | 218,918,000Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 16,996,000Source | 17,993,000Source | 19,110,000Source | 16,623,000Source |
| Operating Lease, Liability, CurrentUSD | 3,539,000Source | 4,188,000Source | 4,482,000Source | 3,712,000Source |
| Accounts Payable, CurrentUSD | 5,629,000Source | 5,187,000Source | 3,722,000Source | 6,314,000Source |
| Operating Lease, Liability, NoncurrentUSD | 1,076,000Source | 4,388,000Source | 7,777,000Source | 12,271,000Source |
| Other Liabilities, NoncurrentUSD | 1,015,000Source | 933,000Source | 691,000Source | 652,000Source |
| Additional Financial Items | ||||
| Accrued Liabilities, CurrentUSD | 7,828,000Source | 8,292,000Source | 10,906,000Source | 6,590,000Source |
cash flow · annual statements
| Line item | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Depreciation, Depletion and AmortizationUSD | 4,713,000Source | 3,690,000Source | 3,288,000Source | 772,000Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | 6,357,000Source | 7,022,000Source | 6,317,000Source | 2,992,000Source |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in Accounts PayableUSD | 257,000Source | 1,907,000Source | -2,572,000Source | 5,258,000Source |
| Deferred Income Tax Expense (Benefit)USD | 210,000Source | -226,000Source | -22,000Source | -4,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | -48,449,000Source | -59,535,000Source | -59,284,000Source | -25,252,000Source |
| Cash flows from investing activities: | ||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | -1,100,000Source | -7,512,000Source | -7,634,000Source | -11,847,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | 1,100,000Source | 7,512,000Source | 7,634,000Source | 11,847,000Source |
| Cash flows from financing activities: | ||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | 9,000Source | 1,000Source | 160,755,000Source | 113,704,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | -41,799,000Source | -92,981,000Source | 88,503,000Source | 80,255,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 131,572,000Source | 173,371,000Source | 266,352,000Source | 177,849,000Source |
| Supplemental disclosure of cash flow information: | ||||
| Income Taxes Paid, NetUSD | 626,000Source | — | — | — |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 7,741,000Source | -25,935,000Source | -5,334,000Source | 3,650,000Source |
| Additional Financial Items | ||||
| Share-based Payment Arrangement, ExpenseUSD | 6,357,000Source | 7,022,000Source | 6,317,000Source | 2,992,000Source |
| Asset Retirement Obligation, Accretion ExpenseUSD | 82,000Source | 75,000Source | 38,000Source | — |
| DepreciationUSD | 4,700,000Source | 3,700,000Source | 3,300,000Source | 800,000Source |
| Foreign Currency Transaction Gain (Loss), before TaxUSD | 5,000Source | — | — | — |
| Foreign Currency Transaction Gain (Loss), RealizedUSD | -1,000,000Source | 3,800,000Source | 2,500,000Source | 400,000Source |
| Gain (Loss) on Disposition of Property Plant EquipmentUSD | -2,000Source | 10,000Source | -156,000Source | — |
| Gain (Loss) on Termination of LeaseUSD | 45,000Source | — | — | — |
| General and Administrative ExpenseUSD | 17,009,000Source | 21,120,000Source | 21,971,000Source | 11,098,000Source |
| Goodwill, Impairment LossUSD | — | — | 100,000Source | 0Source |
| Income Tax Expense (Benefit)USD | 491,000Source | 111,000Source | 37,000Source | 3,000Source |
| Net Income (Loss) Attributable to ParentUSD | -69,665,000Source | -71,176,000Source | -61,099,000Source | -33,199,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | -69,665,000Source | — | — | — |
| Nonoperating Income (Expense)USD | 6,081,000Source | 7,318,000Source | 3,133,000Source | 531,000Source |
| Operating ExpensesUSD | 75,255,000Source | 78,383,000Source | 64,195,000Source | 33,727,000Source |
| Other Nonoperating Income (Expense)USD | 6,081,000Source | 7,318,000Source | 3,133,000Source | 531,000Source |
| Proceeds from Issuance of Common StockUSD | 9,000Source | 1,000Source | — | — |
income statement · annual statements
| Line item | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|
| Operating Income (Loss)USD | -75,255,000Source | -78,383,000Source | -64,195,000Source | -33,727,000Source |
| Other Nonoperating Income (Expense)USD | 6,081,000Source | 7,318,000Source | 3,133,000Source | 531,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | -69,174,000Source | -71,065,000Source | -61,062,000Source | -33,196,000Source |
| Income Tax Expense (Benefit)USD | 491,000Source | 111,000Source | 37,000Source | 3,000Source |
| Net Income (Loss) Attributable to ParentUSD | -69,665,000Source | -71,176,000Source | -61,099,000Source | -33,199,000Source |
| Earnings Per Share, BasicUSD per share | -1.74Source | -1.82Source | — | — |
| Earnings Per Share, DilutedUSD per share | -1.74Source | -1.82Source | — | — |
| Weighted Average Number of Shares Outstanding, Basicshares | 39,973,059Source | 39,139,693Source | — | — |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 39,973,059Source | 39,139,693Source | 28,654,760Source | 1,066,208Source |
| Additional Financial Items | ||||
| Current Income Tax Expense (Benefit)USD | 281,000Source | 337,000Source | 59,000Source | 7,000Source |
| Foreign Currency Transaction Gain (Loss), before TaxUSD | 5,000Source | — | — | — |
| Foreign Currency Transaction Gain (Loss), RealizedUSD | -1,000,000Source | 3,800,000Source | 2,500,000Source | 400,000Source |
| General and Administrative ExpenseUSD | 17,009,000Source | 21,120,000Source | 21,971,000Source | 11,098,000Source |
| Goodwill, Impairment LossUSD | — | — | 100,000Source | 0Source |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | -69,329,000Source | -71,405,000Source | -61,182,000Source | -33,204,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | -69,665,000Source | — | — | — |
| Nonoperating Income (Expense)USD | 6,081,000Source | 7,318,000Source | 3,133,000Source | 531,000Source |
| Operating ExpensesUSD | 75,255,000Source | 78,383,000Source | 64,195,000Source | 33,727,000Source |
| Research and Development ExpenseUSD | 58,246,000Source | 57,263,000Source | 42,224,000Source | 22,629,000Source |